{"id":256634,"date":"2021-01-21T09:47:50","date_gmt":"2021-01-21T08:47:50","guid":{"rendered":"https:\/\/dev.nobelpharma.ch\/?p=256634"},"modified":"2022-01-11T14:47:46","modified_gmt":"2022-01-11T13:47:46","slug":"nouveau-sur-le-marche-suisse-solifenacin-nobel","status":"publish","type":"post","link":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/","title":{"rendered":"NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL"},"content":{"rendered":"<p>Au moment de l\u2019expiration du brevet de Vesicare, NOBEL \u00e9largit sa gamme de produits urologiques avec Solif\u00e9nacine NOBEL. Le principe actif appartient au groupe des parasympatholytiques, qui sont utilis\u00e9s pour le traitement de l\u2019instabilit\u00e9 (hyperactivit\u00e9) v\u00e9sicale. Le Solifenacin est un inhibiteur comp\u00e9titif et s\u00e9lectif du r\u00e9cepteur muscarinique de sous-type M3, qui joue un r\u00f4le important sur le muscle v\u00e9sical dans la diur\u00e8se. Le produit est disponible d\u00e8s maintenant aupr\u00e8s de tous les grossistes et chez NOBEL en vente directe.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Au moment de l\u2019expiration du brevet de Vesicare, NOBEL \u00e9largit sa gamme de produits urologiques avec Solif\u00e9nacine NOBEL. Le principe actif appartient au groupe des parasympatholytiques, qui sont utilis\u00e9s pour le traitement de l\u2019instabilit\u00e9 (hyperactivit\u00e9) v\u00e9sicale. Le Solifenacin est un inhibiteur comp\u00e9titif et s\u00e9lectif du r\u00e9cepteur muscarinique de sous-type M3, qui joue un r\u00f4le important [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":261619,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[47],"tags":[],"class_list":["post-256634","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-non-classifiee"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>NOBEL Pharma Schweiz AG | NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL<\/title>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"NOBEL Pharma Schweiz AG | NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL\" \/>\n<meta property=\"og:description\" content=\"Au moment de l\u2019expiration du brevet de Vesicare, NOBEL \u00e9largit sa gamme de produits urologiques avec Solif\u00e9nacine NOBEL. Le principe actif appartient au groupe des parasympatholytiques, qui sont utilis\u00e9s pour le traitement de l\u2019instabilit\u00e9 (hyperactivit\u00e9) v\u00e9sicale. Le Solifenacin est un inhibiteur comp\u00e9titif et s\u00e9lectif du r\u00e9cepteur muscarinique de sous-type M3, qui joue un r\u00f4le important [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/\" \/>\n<meta property=\"og:site_name\" content=\"NOBEL Pharma Schweiz AG\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/NOBEL-Pharma-Schweiz-AG-113326043777343\/\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-21T08:47:50+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2022-01-11T13:47:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2022\/01\/urogential.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"288\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#\\\/schema\\\/person\\\/8378d622be56d2df12e7407e905707d9\"},\"headline\":\"NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL\",\"datePublished\":\"2021-01-21T08:47:50+00:00\",\"dateModified\":\"2022-01-11T13:47:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/\"},\"wordCount\":100,\"publisher\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nobelpharma.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/urogential.jpg\",\"articleSection\":[\"Non classifi\u00e9(e)\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/\",\"url\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/\",\"name\":\"NOBEL Pharma Schweiz AG | NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/nobelpharma.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/urogential.jpg\",\"datePublished\":\"2021-01-21T08:47:50+00:00\",\"dateModified\":\"2022-01-11T13:47:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/nobelpharma.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/urogential.jpg\",\"contentUrl\":\"https:\\\/\\\/nobelpharma.ch\\\/wp-content\\\/uploads\\\/2022\\\/01\\\/urogential.jpg\",\"width\":1000,\"height\":288},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/2021\\\/01\\\/nouveau-sur-le-marche-suisse-solifenacin-nobel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/nobelpharma.ch\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#website\",\"url\":\"https:\\\/\\\/nobelpharma.ch\\\/\",\"name\":\"NOBEL Pharma Schweiz AG\",\"description\":\"Dem Namen verpflichtet.\",\"publisher\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nobelpharma.ch\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#organization\",\"name\":\"NOBEL Pharma Schweiz AG\",\"url\":\"https:\\\/\\\/nobelpharma.ch\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nobelpharma.ch\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Logo-Nobel-Pharma-AG2.svg\",\"contentUrl\":\"https:\\\/\\\/nobelpharma.ch\\\/wp-content\\\/uploads\\\/2020\\\/06\\\/Logo-Nobel-Pharma-AG2.svg\",\"width\":123.2000000000000028421709430404007434844970703125,\"height\":140,\"caption\":\"NOBEL Pharma Schweiz AG\"},\"image\":{\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/NOBEL-Pharma-Schweiz-AG-113326043777343\\\/\",\"https:\\\/\\\/www.instagram.com\\\/nobelpharmaschweizag\\\/\",\"https:\\\/\\\/www.youtube.com\\\/channel\\\/UCqkCphtCgww0AvmX0njHsUw\\\/?guided_help_flow=5\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/nobelpharma.ch\\\/#\\\/schema\\\/person\\\/8378d622be56d2df12e7407e905707d9\",\"name\":\"admin\",\"sameAs\":[\"https:\\\/\\\/dev.nobelpharma.ch\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"NOBEL Pharma Schweiz AG | NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL","robots":{"index":"noindex","follow":"follow"},"og_locale":"fr_FR","og_type":"article","og_title":"NOBEL Pharma Schweiz AG | NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL","og_description":"Au moment de l\u2019expiration du brevet de Vesicare, NOBEL \u00e9largit sa gamme de produits urologiques avec Solif\u00e9nacine NOBEL. Le principe actif appartient au groupe des parasympatholytiques, qui sont utilis\u00e9s pour le traitement de l\u2019instabilit\u00e9 (hyperactivit\u00e9) v\u00e9sicale. Le Solifenacin est un inhibiteur comp\u00e9titif et s\u00e9lectif du r\u00e9cepteur muscarinique de sous-type M3, qui joue un r\u00f4le important [&hellip;]","og_url":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/","og_site_name":"NOBEL Pharma Schweiz AG","article_publisher":"https:\/\/www.facebook.com\/NOBEL-Pharma-Schweiz-AG-113326043777343\/","article_published_time":"2021-01-21T08:47:50+00:00","article_modified_time":"2022-01-11T13:47:46+00:00","og_image":[{"width":1000,"height":288,"url":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2022\/01\/urogential.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"admin"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#article","isPartOf":{"@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/"},"author":{"name":"admin","@id":"https:\/\/nobelpharma.ch\/#\/schema\/person\/8378d622be56d2df12e7407e905707d9"},"headline":"NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL","datePublished":"2021-01-21T08:47:50+00:00","dateModified":"2022-01-11T13:47:46+00:00","mainEntityOfPage":{"@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/"},"wordCount":100,"publisher":{"@id":"https:\/\/nobelpharma.ch\/#organization"},"image":{"@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#primaryimage"},"thumbnailUrl":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2022\/01\/urogential.jpg","articleSection":["Non classifi\u00e9(e)"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/","url":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/","name":"NOBEL Pharma Schweiz AG | NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL","isPartOf":{"@id":"https:\/\/nobelpharma.ch\/#website"},"primaryImageOfPage":{"@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#primaryimage"},"image":{"@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#primaryimage"},"thumbnailUrl":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2022\/01\/urogential.jpg","datePublished":"2021-01-21T08:47:50+00:00","dateModified":"2022-01-11T13:47:46+00:00","breadcrumb":{"@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#primaryimage","url":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2022\/01\/urogential.jpg","contentUrl":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2022\/01\/urogential.jpg","width":1000,"height":288},{"@type":"BreadcrumbList","@id":"https:\/\/nobelpharma.ch\/fr\/2021\/01\/nouveau-sur-le-marche-suisse-solifenacin-nobel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/nobelpharma.ch\/fr\/"},{"@type":"ListItem","position":2,"name":"NOUVEAU SUR LE MARCH\u00c9 SUISSE : SOLIF\u00c9NACINE NOBEL"}]},{"@type":"WebSite","@id":"https:\/\/nobelpharma.ch\/#website","url":"https:\/\/nobelpharma.ch\/","name":"NOBEL Pharma Schweiz AG","description":"Dem Namen verpflichtet.","publisher":{"@id":"https:\/\/nobelpharma.ch\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nobelpharma.ch\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/nobelpharma.ch\/#organization","name":"NOBEL Pharma Schweiz AG","url":"https:\/\/nobelpharma.ch\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/nobelpharma.ch\/#\/schema\/logo\/image\/","url":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2020\/06\/Logo-Nobel-Pharma-AG2.svg","contentUrl":"https:\/\/nobelpharma.ch\/wp-content\/uploads\/2020\/06\/Logo-Nobel-Pharma-AG2.svg","width":123.2000000000000028421709430404007434844970703125,"height":140,"caption":"NOBEL Pharma Schweiz AG"},"image":{"@id":"https:\/\/nobelpharma.ch\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/NOBEL-Pharma-Schweiz-AG-113326043777343\/","https:\/\/www.instagram.com\/nobelpharmaschweizag\/","https:\/\/www.youtube.com\/channel\/UCqkCphtCgww0AvmX0njHsUw\/?guided_help_flow=5"]},{"@type":"Person","@id":"https:\/\/nobelpharma.ch\/#\/schema\/person\/8378d622be56d2df12e7407e905707d9","name":"admin","sameAs":["https:\/\/dev.nobelpharma.ch"]}]}},"_links":{"self":[{"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/256634","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/comments?post=256634"}],"version-history":[{"count":0,"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/posts\/256634\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/media\/261619"}],"wp:attachment":[{"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/media?parent=256634"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/categories?post=256634"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nobelpharma.ch\/fr\/wp-json\/wp\/v2\/tags?post=256634"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}